Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Invested Capital (2018 - 2025)

Historic Invested Capital for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $360.2 million.

  • TransMedics' Invested Capital rose 7158.92% to $360.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $360.2 million, marking a year-over-year increase of 7158.92%. This contributed to the annual value of $228.6 million for FY2024, which is 6661.78% up from last year.
  • As of Q3 2025, TransMedics' Invested Capital stood at $360.2 million, which was up 7158.92% from $318.1 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Invested Capital registered a high of $360.2 million during Q3 2025, and its lowest value of $50.9 million during Q2 2022.
  • Its 5-year average for Invested Capital is $166.0 million, with a median of $159.5 million in 2024.
  • As far as peak fluctuations go, TransMedics' Invested Capital plummeted by 4277.67% in 2022, and later skyrocketed by 22152.4% in 2023.
  • TransMedics' Invested Capital (Quarter) stood at $67.9 million in 2021, then soared by 176.14% to $187.4 million in 2022, then dropped by 26.78% to $137.2 million in 2023, then skyrocketed by 66.62% to $228.6 million in 2024, then soared by 57.57% to $360.2 million in 2025.
  • Its Invested Capital stands at $360.2 million for Q3 2025, versus $318.1 million for Q2 2025 and $266.3 million for Q1 2025.